Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2022 | 06-2022 | 12-2021 | 06-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 664 | 6,177 | 1,895 | 7,363 | 1,357 |
| Marketable Securities | N/A | 45 | N/A | 46 | N/A |
| Receivables | 80 | 88 | 66 | 12 | 5 |
| Inventories | N/A | 2,491 | N/A | N/A | N/A |
| TOTAL | $754 | $9,598 | $1,981 | $8,378 | $1,369 |
| Non-Current Assets | |||||
| PPE Net | 1,316 | 904 | 2,315 | 327 | 676 |
| Intangibles | N/A | 2,109 | N/A | 1,062 | N/A |
| Other Non-Current Assets | 55 | 177 | 62 | 15 | 0 |
| TOTAL | $1,371 | $3,190 | $2,377 | $1,403 | $676 |
| Total Assets | $2,124 | $12,788 | $4,358 | $9,781 | $2,045 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 46 | 1,166 | 126 | 775 | 102 |
| Accrued Expenses | N/A | 1,110 | N/A | 480 | N/A |
| TOTAL | $49 | $3,320 | $129 | $2,215 | $118 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $389 | $0 | $189 | $0 |
| Total Liabilities | $49 | $3,709 | $129 | $2,405 | $118 |
| Shareholders' Equity | |||||
| Common Shares | 6,364 | 70,718 | 6,353 | 60,587 | 2,065 |
| Retained earnings | -5,392 | -93,453 | -2,981 | -74,852 | -164 |
| Other shareholders' equity | 1,103 | 129 | 856 | 129 | 26 |
| TOTAL | $2,076 | $9,079 | $4,229 | $7,377 | $1,927 |
| Total Liabilities And Equity | $2,124 | $12,788 | $4,358 | $9,781 | $2,045 |